Quality of life of patients with lung cancer

Jacek Polanski, Beata Jankowska-Polanska, Joanna Rosinczuk, Mariusz Chabowski, Anna Szymanska-Chabowska, Jacek Polanski, Beata Jankowska-Polanska, Joanna Rosinczuk, Mariusz Chabowski, Anna Szymanska-Chabowska

Abstract

Lung cancer is the major cause of oncologic-related death worldwide. Due to delayed diagnosis, 5-year survival rate accounts for only 15%. Treatment includes surgery, adjuvant chemotherapy, and radiation therapy; however, it is burdened by many side effects. Progress of the disease, severity of its symptoms, and side effects decrease significantly the quality of life (QoL) in those patients. The level of self-assessed QoL helps in predicting survival, which is especially important among patients receiving palliative care. Patients assess their functioning in five dimensions (physical, psychological, cognitive, social, and life roles), severity of symptoms, financial problems, and overall QoL. The QoL in lung cancer patients is lower than in healthy population and patients suffering from other malignancies. It is affected by the severity and the number of symptoms such as fatigue, loss of appetite, dyspnea, cough, pain, and blood in sputum, which are specific for lung tumors. Fatigue and respiratory problems reduce psychological dimension of QoL, while sleep problems reduce cognitive functioning. Physical dimension (related to growing disability) decreases in most of the patients. Also, most of them are unable to play their family and social roles. The disease is a frequent reason of irritation, distress, and depression. Management of the disease symptoms may improve QoL. Controlling the level of fatigue, pulmonary rehabilitation, and social and spiritual support are recommended. Early introduction of tailored palliative treatment is a strategy of choice for improvement of QoL in lung cancer patients.

Keywords: adverse events; lung cancer; prognostic factor; public health medicine; quality of life; survival.

References

    1. John L. Self-care strategies used by patients with lung cancer to promote quality of life. Oncol Nurs Forum. 2010;37(3):339–347.
    1. Leppert W. Jakość życia chorych na zaawansowanego raka płuca objętych opieką paliatywną, stacjonarną i domową [Quality of life in patients with advanced lung cancer at home palliative care at the in-patient palliative care unit] Medycyna Paliatywna. 2010;1:25–34. Polish.
    1. Braun DP, Gupta D, Staren ED. Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer. 2011;11:353.
    1. Efficace F, Bottomley A, Smit EF, et al. Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Ann Oncol. 2006;17(11):1698–1704.
    1. Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med. 1995;41(10):1383–1394.
    1. Siegrist J, Junge A. Conceptual and methodological problems in research on the quality of life in clinical medicine. Soc Sci Med. 1989;29(3):463–468.
    1. Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K. Validation of the Polish version of the EORTC QLQ-C30 and the QLQ-OG25 for the assessment of health-related quality of life in patients with esophagi-gastric cancer. J Psychosoc Oncol. 2013;31(2):191–203.
    1. Lemonnier I, Baumann C, Jolly D, et al. Solitary pulmonary nodules: consequences for patient quality of life. Qual Life Res. 2011;20(1):101–109.
    1. Lövgren M, Tishelman C, Sprangers M, Koyi H, Hamberg K. Symptoms and problems with functioning among women and men with inoperable lung cancer – a longitudinal study. Lung Cancer. 2008;60(1):113–124.
    1. Hermann CP, Looney SW. Determinants of quality of life in patients near the end of life: a longitudinal perspective. Oncol Nurs Forum. 2011;38(1):23–31.
    1. Liao YC, Shun SC, Liao WY, Yu CJ, Yang PC, Lai YH. Quality of life and related factors in patients with newly diagnosed advanced lung cancer: a longitudinal study. Oncol Nurs Forum. 2014;41(2):E44–E55.
    1. Zimmermann C, Burman D, Swami N, et al. Determinants of quality of life in patients with advanced cancer. Support Care Cancer. 2011;19(5):621–629.
    1. Mor V, Allen S, Malin M. The psychosocial impact of cancer on older versus younger patients and their families. Cancer. 1994;74:2118–2127.
    1. Iyer S, Taylor-Stokes G, Roughley A. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany. Lung Cancer. 2013;81(2):288–293.
    1. Gralla RJ. Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life. Oncologist. 2004;9(Suppl 6):14–24.
    1. Henoch I, Bergman B, Gustafsson M, Gaston-Johansson F, Danielson E. The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer. J Pain Symptom Manage. 2007;34(4):370–379.
    1. Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer. 2005;103(2):377–382.
    1. Nowicki A, Krzyminska J, Kowalewski J. Ocena jakości życia chorych leczonych operacyjnie z powodu raka płuca [Estimation of quality of life in patients after surgery for lung cancer] Wspolcz Onkol. 2006;10(9):468–474. Polish.
    1. Cooley ME. Quality of life in persons with non-small cell lung cancer: a concept analysis. Cancer Nurs. 1998;21(3):151–161.
    1. Gift AG, Jablonski A, Stommel M, Given CW. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31(2):203–210.
    1. Tishelman C, Degner LF, Mueller B. Measuring symptom distress in patients with lung cancer: a pilot study of experienced intensity and importance of symptoms. Cancer Nurs. 2000;23(2):82–90.
    1. Butt Z, Rosenbloom SK, Abernethy AP, et al. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. JNCCN. 2008;6(5):448–455.
    1. Ostlund U, Wennman-Larsen A, Gustavsson P, Wengström Y. What symptom and functional dimensions can be predictors for global ratings of overall quality of life in lung cancer patients? Support Care Cancer. 2007;15(10):1199–1205.
    1. Dagnelie PC, Pijls-Johannesma MCG, Lambin P, Beijer S, De Ruysscher D, Kempen GIJM. Impact of fatigue on overall quality of life in lung and breast cancer patients selected for high-dose radiotherapy. Ann Oncol. 2007;18(5):940–944.
    1. Wachowicz M, Furmanik F. Ocena jakości życia chorych na (NDRP) niedrobnokomórkowego raka płuca leczonych chirurgiczne lub przedoperacyjną chemioterapią i następową resekcją [Quality of life assessment in patients with non-small cell lung cancer treated surgically or with preoperative chemotherapy followed by surgery] Pneumonol Alergol Pol. 2003;71(3–4):121–131. Polish.
    1. Zielinska-Wieczkowska H, Beltakowski J. Jakość życia pacjentów z chorobą nowotworową poddanych chemioterapii [Quality of life in cancer patients undergoing chemotherapy] Wspolcz Onkol. 2010;14(3):276–280. Polish.
    1. Kubaszewska M, Skowronek J, Chichel A, Kanikowski M. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irradiated lung cancer. Neoplasma. 2008;55(3):239–245.
    1. Karczmarek-Borowska B, Pelc M, Rabiej E, Gradalska-Lampart M. Jakość życia chorych na niedrobnokomórkowego raka płuca poddanych chemioterapii [The quality of life of non-small cell lung cancer patients treated with chemotherapy] Pneumonol Alergol Pol. 2014;82(4):349–357. Polish.
    1. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28.
    1. Carlsen K, Jensen AB, Jacobsen E, Krasnik M, Johansen C. Psychosocial aspects of lung cancer. Lung Cancer. 2005;47(3):293–300.
    1. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001;31(2–3):233–240.
    1. Hopwood P, Stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. J Clin Oncol. 2000;18(4):893–903.
    1. Li TC, Li CI, Tseng CH, et al. Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health. 2012;12:790.
    1. Pirl WF, Greer JA, Traeger L, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30(12):1310–1315.
    1. Kurowska K, Weilandt K. Sense of coherence and coping with the disease in patients with a diagnosis of lung cancer. Nurs Top. 2010;1(1):11–16.
    1. Porter LS, Keefe FJ, Garst J, McBride CM, Baucom D. Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress. Pain. 2008;137(2):306–315.
    1. Mock V, Atkinson A, Barsevick A, et al. NCCN practice guidelines for cancer-related fatigue. Oncology. 2000;14(11A):151–161.
    1. Benzo RP. Pulmonary rehabilitation in lung cancer: a scientific opportunity. JCRP. 2007;27(2):61–64.
    1. Sak J, Sagan D, Wiechetek M, Pawlikowski J. Suboptimal perception of illness due to self-realization constraints impairs psychological welfare in surgical patients. Eur J Cardiothorac Surg. 2012;41:824–828.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する